COVID-19 and Thyroid Illness
Abstract
We present a case series of three cases of thyroid dysfunction such as Hashimoto thyroiditis, Graves’ disease and sub acute thyroiditis presenting in few weeks after resolution of acute phase of COVID -19 infection in patients with no prior thyroid disease. Physicians should be acquainted with possible relationship of COVID-19 and thyroid dysfunction.
We discuss clinical manifestation, diagnostic evaluation and ensuing management and follow-up in each patient having thyroid dysfunction after getting positive for covid-19.
The temporal relationship highlights the association of different forms of thyroid dysfunction with COVID-19 calling for further research to clarify the connections and answers to many questions.
How to Cite This Article
Latif H, Iqbal A, Farooq N, Rathore R. COVID-19 and Thyroid Illness. J Pak Soc Intern Med. 2022;3(3):216–219. doi:10.70302/jpsim.v3i3.2242
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Caron P. Thyroid disorders and SARS-CoV-2 infection: from pathophysiological mechanism to patient management. Ann Endocrinol (Paris). 2020;81(5):507-10.
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18):1708-20.
- Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 2020; 43(7):1027-31.
- Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004;203(2):622-30.
- Desailloud R, Hober D. Viruses and thyroiditis: An update. Virol J. 2009;6(1):5.
- Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine 2020; doi: https://doi.org/10.1007/s12020-020-02364-8. doi:10.1007/s12020-020-02364-8
- Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest 2020:1–2. https:// doi.org/10.1007/s40618-020-013118. doi:10.1007/s40618-020-013118
- Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;doi: https://doi.org/10.1007/s40618-020-01276-8. doi:10.1007/s40618-020-01276-8
- Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty.2020;9(1):45.
- Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004;203(2):622-30.
- Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 2020;153(6):725-33.
- Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 2020;396(10247):320-32.
- Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al. Detection of SARS-COV-2 receptor ACE- 2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44(5):1085-90.
- Lania A, Sandri MT, Cellini M, et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381-7.
- Idrose AM. Acute and emergency care for thyrotoxicosis and thyroid storm. Acute Med Surg. 2015;2(3):147-57.
- Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
- Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739-41.
- Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020; doi: https://doi.org/10.1007/s1115. doi:10.1007/s1115
- Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020;43(8):1169-1170.
- Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest 2021;44(5):891- 904.
- Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: THE THYRCOV STUDY. Eur J Endocrinol 2020;183(4):381-7.
- Chen M, Zhou W, Xu W. TThyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid 2021; 31(1):8-11.
- Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab 2021;106(10):e926–35.
- Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest 2020;43(12):1527–8.
- Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, et al. Clinical Characteristics of 852 Patients With Subacute Thyroiditis Before Treatment. Intern Med. 2008; 47(8):725–9.
- Benbassat CA, Olchovsky D, Tsvetov G, Shimon I. Subacute Thyroiditis: Clinical Characteristics and Treatment Outcome in Fifty-Six Consecutive Patients Diagnosed Between 1999 and 2005. J Endocrinol Invest. 2007;30(8):631–5.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.